Home › NDC Lookup › RxCUI directory › RxCUI 309081

Cefprozil 50 MG/ML Oral Suspension — RxCUI 309081

RxNorm drug concept · Semantic clinical drug
RxCUI 309081 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 20 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI309081
Official nameCefprozil 50 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascefprozil 250 MG per 5 ML Oral Suspension; cefprozil 250 MG in 5 mL Oral Suspension
FDA products mapped8
Package NDCs mapped20
Reported Medicaid activity (SDUD)30,578 prescriptions · 37 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cefprozil: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Cefprozil treats bacterial infections — not viral ones like colds or flu. It's commonly prescribed for strep throat, ear infections (in children 6 months and up), sinus infections,...
  • What kinds of infections does cefprozil treat?
  • Good news — you can take it with or without food, whichever is easier on your stomach. Food doesn't change how much of the medication gets into your system. It may very slightly de...
  • Can I take cefprozil with food, or does it need to be on an empty stomach?
📖 Read our full Cefprozil guide →

🕸️ Concept Web — How Cefprozil 50 MG/ML Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cefprozil 50 MG/ML Oral Suspension RxCUI 309081

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Cefprozil 19552
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cefprozil Oral Suspension 371335
    • Cefprozil Oral Liquid Product 1161216
    • Cefprozil Oral Product 1161217
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • Oral Product 1151131
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Cefprozil 50 MG/ML 315599

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cefprozil 50 MG/ML SCDC · 315599
  • Cefprozil Oral Suspension SCDF · 371335
  • Cefprozil Oral Liquid Product SCDG · 1161216
  • Cefprozil Oral Product SCDG · 1161217

📦 FDA Products & Package NDCs

8 products · 20 package NDCs
20 package NDCs map to RxCUI 309081 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50090-3226-00 50 mL in 1 BOTTLE (50090-3226-0) Cefprozil A-S Medication Solutions 2017-10-30
57237-0034-01 100 mL in 1 BOTTLE (57237-034-01) Cefprozil Rising Pharma Holdings, Inc. 2007-01-30
57237-0034-50 50 mL in 1 BOTTLE (57237-034-50) Cefprozil Rising Pharma Holdings, Inc. 2007-01-30
57237-0034-75 75 mL in 1 BOTTLE (57237-034-75) Cefprozil Rising Pharma Holdings, Inc. 2007-01-30
57237-0035-01 100 mL in 1 BOTTLE (57237-035-01) Cefprozil Rising Pharma Holdings, Inc. 2007-01-30
57237-0035-50 50 mL in 1 BOTTLE (57237-035-50) Cefprozil Rising Pharma Holdings, Inc. 2007-01-30
57237-0035-75 75 mL in 1 BOTTLE (57237-035-75) Cefprozil Rising Pharma Holdings, Inc. 2007-01-30
65862-0099-01 100 mL in 1 BOTTLE (65862-099-01) Cefprozil Aurobindo Pharma Limited 2007-01-30
65862-0099-50 50 mL in 1 BOTTLE (65862-099-50) Cefprozil Aurobindo Pharma Limited 2007-01-30
65862-0099-75 75 mL in 1 BOTTLE (65862-099-75) Cefprozil Aurobindo Pharma Limited 2007-01-30
65862-0100-01 100 mL in 1 BOTTLE (65862-100-01) Cefprozil Aurobindo Pharma Limited 2007-01-30
65862-0100-50 50 mL in 1 BOTTLE (65862-100-50) Cefprozil Aurobindo Pharma Limited 2007-01-30
65862-0100-75 75 mL in 1 BOTTLE (65862-100-75) Cefprozil Aurobindo Pharma Limited 2007-01-30
68180-0273-01 50 mL in 1 BOTTLE (68180-273-01) CEFPROZIL Lupin Pharmaceuticals, Inc. 2026-05-04
68180-0273-02 75 mL in 1 BOTTLE (68180-273-02) CEFPROZIL Lupin Pharmaceuticals, Inc. 2026-05-04
68180-0273-03 100 mL in 1 BOTTLE (68180-273-03) CEFPROZIL Lupin Pharmaceuticals, Inc. 2026-05-04
68180-0401-03 100 mL in 1 BOTTLE (68180-401-03) CEFPROZIL Lupin Pharmaceuticals, Inc. 2005-12-01
68180-0402-01 50 mL in 1 BOTTLE (68180-402-01) CEFPROZIL Lupin Pharmaceuticals, Inc. 2005-12-01
68180-0402-02 75 mL in 1 BOTTLE (68180-402-02) CEFPROZIL Lupin Pharmaceuticals, Inc. 2005-12-01
68180-0402-03 100 mL in 1 BOTTLE (68180-402-03) CEFPROZIL Lupin Pharmaceuticals, Inc. 2005-12-01
Observed labelers: Lupin Pharmaceuticals, Inc. (7) · Aurobindo Pharma Limited (6) · Rising Pharma Holdings, Inc. (6) · A-S Medication Solutions (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.